[go: up one dir, main page]

DK151886B - METHOD OF ANALOGUE FOR THE PREPARATION OF (DL) OR (1) 5-BENZOYL-1,2-DIHYDRO-3H-PYRROLOOE1,2-AAAPYRROL-1-CARBOXYL ACID ESTERS - Google Patents

METHOD OF ANALOGUE FOR THE PREPARATION OF (DL) OR (1) 5-BENZOYL-1,2-DIHYDRO-3H-PYRROLOOE1,2-AAAPYRROL-1-CARBOXYL ACID ESTERS Download PDF

Info

Publication number
DK151886B
DK151886B DK307577AA DK307577A DK151886B DK 151886 B DK151886 B DK 151886B DK 307577A A DK307577A A DK 307577AA DK 307577 A DK307577 A DK 307577A DK 151886 B DK151886 B DK 151886B
Authority
DK
Denmark
Prior art keywords
dihydro
pyrrole
pyrrolo
dimethyl
carboxylate
Prior art date
Application number
DK307577AA
Other languages
Danish (da)
Other versions
DK307577A (en
DK151886C (en
Inventor
Joseph M Muchowski
Arthur F Kluge
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27107410&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK151886(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US05/771,286 external-priority patent/US4089969A/en
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of DK307577A publication Critical patent/DK307577A/en
Priority to DK480080A priority Critical patent/DK151337C/en
Priority to DK479780A priority patent/DK152733C/en
Priority to DK479980A priority patent/DK151336C/en
Priority to DK479880A priority patent/DK151335C/en
Publication of DK151886B publication Critical patent/DK151886B/en
Application granted granted Critical
Publication of DK151886C publication Critical patent/DK151886C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)

Description

DK 151886 BDK 151886 B

Den foreliggende opfindelse angår en analogifremgangsmåde tf.l fremstilling af hidtil ufeendte (dll eller (II 5-benzoyl*^lf 2T^ihydro^3HT· pyrrolo[l,2-a]pyrrol^l'K2arBoxylsyreestere af den almene formel r1_CXDtX/coos2· •ti I ΙΟ 3J_J2 2The present invention relates to an analogous process for the preparation of hitherto undefined (dll or (II 5-benzoyl * l) 2T ^ ihydro ^ 3HT · pyrrolo [1,2-a] pyrrole 1'K2arBoxylic acid esters of the general formula r1_CXDtX / coos2 · • ti I ΙΟ 3J_J2 2

DK 151886 BDK 151886 B

hvori R betegner hydrogen eller en alkylgruppe med 1-4 carbonatomer, R"*· betegner hydrogen, en alkylgruppe med 1-4 carbonatomer, en alk= 2 oxygruppe med 1-4 carbonatomer, chlor, fluor eller brom, og R er en alkylgruppe med'1-4 carbonatomer, hvilken fremgangsmåde er ejendommelig ved det i kravets kendetegnende del anførte, 5 De ved fremgangsnåden ifølge den foreliggende opfindelse fremstillede forbindelser, som beskrevet ovenfor og mere indgående beskrives nedenfor, udøver antiinflammatorisk, analgetisk og antipyretisk virkning og er således nyttige ved behandlingen af inflammation, smerte og/eller py-reksi hos pattedyr, som beskrevet nærmere i det følgende. De er også 10 glatmuskelafslappelsesmidler.wherein R represents hydrogen or an alkyl group of 1-4 carbon atoms, R "* represents hydrogen, an alkyl group of 1-4 carbon atoms, an alk = 2 oxy group of 1-4 carbon atoms, chlorine, fluorine or bromine, and R is an alkyl group having the 1-4 carbon atoms which are characterized by the characterizing part of the claim. The compounds prepared by the process of the present invention, as described above and more fully described below, exert anti-inflammatory, analgesic and antipyretic action and are thus useful in the treatment of inflammation, pain, and / or pyrexia in mammals, as described in more detail below, They are also 10 smooth muscle relaxants.

De hidtil ukendte forbindelser af formlen (XX), der er beskrevet nedenfor, eksisterer som par af optiske isomere (eller enantiomorfe), dvs. en' (dl)-blanding,’ Den foreliggende opfindelse angår imidler-15 tid, som det fremgår, fremstillingen af såvel (1)-formen som (dl)-blandingeme deraf.The novel compounds of formula (XX) described below exist as pairs of optical isomers (or enantiomorphs), i.e. However, as will be seen, the present invention relates to the preparation of both the (1) form and (dl) mixtures thereof.

De hidtil ukendte (dl)-forbindelser kan ifølge den foreliggende opfindelse . fremstilles ved hjælp af en fremgangsmåde, der kan illu-20 streres ved hjælp af følgende reaktions skema;, idet det skal bemærkes, at det kun er sids.te trin i reaktions skemaet, der illustrerer fremgangsmåden ifølge den foreliggende opfindelse. Skemaet illustrerer iøvrigt mulige synteseveje ved fremstillingen af udgangsmaterialet (X) for fremgangsmåden ifølge opfindelsen.The novel (dl) compounds can according to the present invention. is prepared by a process which can be illustrated by the following reaction scheme; it should be noted that only the last step of the reaction scheme illustrates the process of the present invention. The diagram further illustrates possible synthetic pathways in the preparation of the starting material (X) for the process of the invention.

25 30 3525 30 35

3 DK 151886 B3 DK 151886 B

HH, . COOCH, fcOOCHj [ + R * H || C«2 I coocH, ~" J COOCH 2 3 J (III)HH,. COOCH, fcOOCHj [+ R * H || C «2 I coocH, ~" J COOCH 2 3 J (III)

CH, O vA HNCH, O vA HN

I ΧΛ, H0C~CH- OH (II) >sffc. 2. 2I ΧΛ, H0C ~ CH- OH (II)> sffc. 2. 2

. · . Nr® OH. ·. No.® OH

(I) .(I).

COOCHj N^R COOCH3 \KjCcoocH3 * ’ XX/c°och3 ch2 \ i I 2 \ H-C-CH, CH~ (V) \ · I (IV).COOCHj N ^ R COOCH3 \ KjCcoocH3 * 'XX / c ° and3ch2 \ i I 2 \ H-C-CH, CH ~ (V) \ · I (IV).

I 2 \ OHI 2 \ OH

r 0S02CH3 \ __^cooch3 * Rv^_^cooch3 ^ iNX/coocH3 ?H2 , . (VII) I (vi)r 0S02CH3 \ __ ^ cooch3 * Rv ^ _ ^ cooch3 ^ iNX / coocH3? H2 ,. (VII) I (vi)

IH2CIH2C

R _^COOH R jCOOHR _ ^ COOH R jCOOH

T^IycooR2 " TjX cooh ^- (IX) (VIII) t Rv XX/COOP'2 ,-T ^ IycooR2 "TjX cooh ^ - (IX) (VIII) t Rv XX / COOP'2, -

i_J 0 I—Ii_J 0 I — I

(X) (XI) 4(X) (XI) 4

DK 151886 BDK 151886 B

1 2 hvori R og R har den ovenfor anførte betydning, og R er en lavere alkylgruppe med 1-4 carbonatomer, f.eks. methyl, ethyl, isopropyl og n-butyl.Wherein R and R are as defined above and R is a lower alkyl group of 1-4 carbon atoms, e.g. methyl, ethyl, isopropyl and n-butyl.

5 Ved gennemførelse af den ovennævnte fremgangsmåde til fremstilling af en forbindelse af formlen (IV)', hvori R er hydrogen,omsættes ækvi= molære mængder af ethanolamin (I) og dimethyl-1,3-acetonedicarboxylat (II) til dannelse af en vinylamin af formlen (III), der så kan behandles under vandfrie betingelser med et 2-halogenaldehyd.By carrying out the above process for preparing a compound of formula (IV) wherein R is hydrogen, equilibrium amounts of ethanolamine (I) and dimethyl-1,3-acetone dicarboxylate (II) are formed to form a vinylamine. of formula (III) which can then be treated under anhydrous conditions with a 2-haloaldehyde.

1010

Til fremstilling af forbindelserne af formlen (IV), hvori R er lavere alkylgruppe,behandles en vandig blanding af ethanolamin (I) og dimethyl-1,3-acetonedicarboxylat (II) med en forbindelse af formlenTo prepare the compounds of formula (IV) wherein R is lower alkyl group, an aqueous mixture of ethanolamine (I) and dimethyl-1,3-acetone dicarboxylate (II) is treated with a compound of formula

OISLAND

15 3 "15 3 "

R -C-CH2XR -C-CH2X

3 hvori X er brom eller chlor, og R er en lavere alkylgruppe.3 wherein X is bromine or chlorine and R is a lower alkyl group.

^ Forestring af forbindelse (IV) med methansulfonylchlorid i nærværelse af en tertiær amin resulterer i et tilsvarende mesylat' af formlen (V), som så omdannes til den tilsvarende N-(2-jodethyl)-pyrrol af formlen (VI) ved reaktion med natriumjodid i acetonitrilopløs-ning. Forbindelserne af formlen (VII) opnås ud fra forbindelserne af formlen (VI) ved behandling med natriumhydrxd i et egnet inaktivt 2 5 organisk opløsningsmiddel, såsom dimethylformamid.Esterification of compound (IV) with methanesulfonyl chloride in the presence of a tertiary amine results in a corresponding mesylate 'of formula (V) which is then converted to the corresponding N- (2-iodoethyl) pyrrole of formula (VI) by reaction with sodium iodide in acetonitrile solution. The compounds of formula (VII) are obtained from the compounds of formula (VI) by treatment with sodium hydroxide in a suitable inert organic solvent such as dimethylformamide.

Forbindelserne af formlen'(VII) kan alternativt fremstilles ved direkte ringslutning af mesylat (V) med natriumhydrid i dimethylfor= ^ mamidopløsning..The compounds of formula (VII) may alternatively be prepared by direct cyclization of mesylate (V) with sodium hydride in dimethylformamide solution.

Forbindelsen af formlen (VIII) er afledt af forbindelsen (VII) ved hydrolyse under basiske betingelser. Carboxylsyregruppen i C-l-stil- lingen i forbindelse (VIII) forestres så selektivt ved behandling med en lavere alifatisk alkohol til dannelse af dat tilsvarende mono= 35 carboxylat af formlen (IX), som så decarboxyleres til de tilsvarende forbindelser af formlen (X), hvilket er udgangsmaterialerne for fremgangsmåden ifølge opfindelsen.The compound of formula (VIII) is derived from the compound (VII) by hydrolysis under basic conditions. The carboxylic acid group of the C-position of compound (VIII) is then selectively esterified by treatment with a lower aliphatic alcohol to give the corresponding mono = 35 carboxylate of formula (IX) which is then decarboxylated to the corresponding compounds of formula (X). which are the starting materials for the process according to the invention.

5 DK 151886 Β τ5 DK 151886 Β τ

Decarboxylering af de monoforestrede forbindelser (IX) til de tilsvarende forbindelser med formlen (X), nøglemellemprodukterne ved fremgangsmåden til fremstilling af forbindelserne ifølge den foreliggende opfindelse, opnås ved opvarmning af (IX) ved en forhøjet temperatur af størrelsesordenen fra ca. 230°C til ca. 280°C i et tidsrum, som er 5 tilstrækkeligt til at fuldende reaktionen. Reaktionsforløbet kan følges ved hjælp af carbondioxidudviklingshastigheden og tyndtlagskroma-tografisk analyse, idet decarboxylering almindeligvis er afsluttet i løbet af fra ca. 45 til ca. 90 minutter. Reaktionsproduktet, nemlig alkyl-l,2-dihydro-3H-pyrrolo[l,2-a]pyrrol-l-carboxylat og 6-alkylde-10 rivaterne deraf (X), kan renses ved hjælp af kromatografiske metoder. Alternativt og specielt til decarboxylering af små portioner af forbindelse (IX) kan reaktionsproduktet (X) destilleres direkte fra reaktionsbeholderen.Decarboxylation of the mono-esterified compounds (IX) to the corresponding compounds of formula (X), the key intermediates of the process for the preparation of the compounds of the present invention, is obtained by heating (IX) at an elevated temperature of the order of about 230 ° C to approx. 280 ° C for a time sufficient to complete the reaction. The course of the reaction can be followed by the carbon dioxide development rate and thin layer chromatographic analysis, with decarboxylation usually completed in about 10 minutes. 45 to approx. 90 minutes. The reaction product, namely alkyl-1,2-dihydro-3H-pyrrolo [1,2-a] pyrrole-1-carboxylate and its 6-alkyl derivatives (X), can be purified by chromatographic methods. Alternatively and especially for decarboxylating small portions of compound (IX), the reaction product (X) can be distilled directly from the reaction vessel.

Den af fremgangsmåden ifølge opfindelsen omfattede kondensation af en forbindelse (X) med et amid af formlen C0N(CHg)g R1 20 hvori R·*· har den ovenfor anførte betydning, giver det tilsvarende alkyl-5rbenzoyl-l, 2-dihydro~3H-pyrrolo[1,2-a]pyrrol-l-carboxylat (XI).The condensation of the process according to the invention comprises a compound (X) having an amide of the formula CON (CHg) g R1 in which R R has the meaning given above, giving the corresponding alkyl-5-benzoyl-1,2-dihydro-3H -pyrrolo [1,2-a] pyrrole-1-carboxylate (XI).

Denne reaktion gennemføres i et inaktivt organisk aprotisk opløsningsmiddel og i nærværelse af phosphoroxychlorid ved tilbagesvalingstemperatur i fra ca. 1 til ca. 175 timer under en inaktiv atmosfære ef-25 terfulgt af yderligere tilbagesvaling i nærværelse af natriumacetat i fra ca. 2 til ca. 10 timer. I stedet for phosphoroxychlorid kan der alternativt anvendes andre syrechlorider såsom phosgen eller oxa-lylchlorid.This reaction is carried out in an inert organic aprotic solvent and in the presence of phosphorus oxychloride at reflux temperature for from ca. 1 to approx. 175 hours under an inert atmosphere followed by further reflux in the presence of sodium acetate for from ca. 2 to approx. 10 hours. Alternatively, instead of phosphorus oxychloride, other acid chlorides such as phosgene or oxalyl chloride may be used.

30 Ved de foretrukne udførelsesformer gennemføres denne kondensation ved at sætte en opløsning af forbindelse (X) i et egnet opløsningsmiddel til en tidligere tilbagesvalet blanding af 1,1-5 molærækvivalenter af både det ønskede amid og phosphoroxychlorid i det samme opløsningsmiddel, tilbagesvale den således opnåede reaktionsblanding i fra ca. 6 35 til ca. 72 timer under en argonatmosfære og derefter hertil sætte fra ca. 3 til ca. 10 molærækvivalenter natriumacetat efterfulgt af en yderligere tilbagesvalingsperiode på fra ca. 4 til ca. 6 timer.In the preferred embodiments, this condensation is carried out by adding a solution of compound (X) in a suitable solvent to a previously refluxed mixture of 1.1-5 molar equivalents of both the desired amide and phosphorus oxychloride in the same solvent, refluxing the thus obtained reaction mixture for from ca. 6 35 to approx. 72 hours under an argon atmosphere and thereafter set from approx. 3 to approx. 10 molar equivalents of sodium acetate followed by a further reflux period of from approx. 4 to approx. 6 hours.

DK 151886 BDK 151886 B

66

Passende opløsningsmidler til denne reaktion er de halogenerede hydro-carboner såsom dichlormethan, 1,2-dichlorethan, chloroform,eller carbontetrachlorid, dimethoxyethan og tetrahydrofuran. Det fore trukne opløsningsmiddel er 1,2-dichlorethan.Suitable solvents for this reaction are the halogenated hydrocarbons such as dichloromethane, 1,2-dichloroethane, chloroform, or carbon tetrachloride, dimethoxyethane and tetrahydrofuran. The preferred solvent is 1,2-dichloroethane.

5 N,N-dimethylarylamiderne, der anvendes i de følgende eksempler, er: N,N-dimethyl-o-toluamid, N,N-dimethyl-m-toluamid, N,N-dimethyl-p-toluamid, N,N-dimethy1-p-methoxy-benz amid, 10 N,N-dimethy1-p-ethoxy-benzamid, N,N-dimethyl-o-chlor-benzamid, N,N-dimethyl-m-chlor-benzamid, N,N-dimethyl-p-chlor-benzamid, N,N-dimethyl-p-fluor-benzamid og 15 N,N-dimethyl-m-ethoxy-benzamid.The N, N-dimethylarylamides used in the following examples are: N, N-dimethyl-o-toluamide, N, N-dimethyl-m-toluamide, N, N-dimethyl-p-toluamide, N, N- dimethyl-p-methoxy-benzamide, N, N-dimethyl-p-ethoxy-benzamide, N, N-dimethyl-o-chloro-benzamide, N, N-dimethyl-m-chloro-benzamide, N, N- dimethyl-p-chloro-benzamide, N, N-dimethyl-p-fluoro-benzamide and N, N-dimethyl-m-ethoxy-benzamide.

Disse amider,er kendte, i handelen værende forbindelser eller kan fremstilles på sædvanlig måde ud fra de tilsvarende syrer, d.v.s. ved om- | dannelse til syrechloriderne efterfulgt af behandling med dimethylamin.These amides are known, commercially available compounds or can be prepared in the usual manner from the corresponding acids, i.e. by about- | formation to the acid chlorides followed by treatment with dimethylamine.

Forbindelserne med formlen (XI) kan i overensstemmelse med kendte 20 metoder i teknikken spaltes til opnåelse af de tilsvarende enkelte isomere deraf.The compounds of formula (XI) may be cleaved in accordance with known methods in the art to obtain the corresponding single isomers thereof.

Til belysning heraf skal nævnes, at (11 -syreisomere Qg(d)-s.yreisomere af de til forbindelserne (XI) svarende syrer med formlen (A) kan opnås 25 ved at anvende den kendte teknik med højtryksvæskekromatografi (HPLC) i 7 ’ :To illustrate this, it should be mentioned that (11-acid isomers Qg (d) -s-acid isomers of the acids corresponding to compounds (XI) of formula (A) can be obtained by using the prior art high-pressure liquid chromatography (HPLC) for 7 '. :

DK 151886 BDK 151886 B

på α-phenethyldiastereoisomere estere af forbindelserne med formlen (A) efterfulgt af syrespaltning. Forbindelserne med formlen (A), hvori R og begge er hydrogen, kan således f.eks. udsættes for en yderligere behandling i overensstemmelse med følgende diagram: COOII ^-- adskillige trin.on α-phenethyl diastereoisomeric esters of the compounds of formula (A) followed by acid cleavage. Thus, the compounds of formula (A) wherein R and both are hydrogen may e.g. is subjected to further treatment in accordance with the following diagram: COOII ^ - several steps.

. Φ i’iA1) - (1) -^syreisomer-' (1) -oc-phenethylester - i x (Ax) - (d) - syreisomer- (1) -α-phenethylester j ['.separering under anvendelse af .. · . · ' .høj tryks væske- * .. Φ i'iA1) - (1) - ^ acid isomer- '(1) -oc-phenethyl ester - ix (Ax) - (d) - acid isomer- (1) -α-phenethyl ester j [' separation using .. ·. · '. High pressure liquid- *.

. ·' kroma^jgrafi · • (a^) - (1) -^syre&somei^ . [ . : λ \· (A^) - (d) -/syreisomer -(1) -phenethylester t V ' ' i (A)-(l)-syreisomer . (A )-(d)-syreisomer .-. · 'Kroma ^ jgrafi · • (a ^) - (1) - ^ acid & somei ^. [. : λ \ · (A ^) - (d) - / acid isomer - (1) -phenethyl ester t V '' in (A) - (l) -isomer. (A) - (d) acidomer.

Det må forstås, at isoleringen af de heri beskrevne forbindelser om 5 ønsket kan gennemføres ved hjælp af enhver egnet separerings- eller rensningsmetode, såsom f.eks. ekstraktion, filtrering, inddampning, destillation, krystallisation, tyndtlagskromatografi eller søjlekromatografi, højtryksvæskekromatografi (HPLC) eller en kombination af disse metoder. I eksemplerne belyses egnede separerings- og isoleringsmetoder. Der kan naturligvis også anvendes andre ækvivalente separerings- eller isoleringsmetoder.It is to be understood that, if desired, the isolation of the compounds described herein may be accomplished by any suitable separation or purification method, such as e.g. extraction, filtration, evaporation, distillation, crystallization, thin layer chromatography or column chromatography, high pressure liquid chromatography (HPLC) or a combination of these methods. Examples illustrate suitable separation and isolation methods. Of course, other equivalent separation or isolation methods can also be used.

DK 151886BDK 151886B

. 8 ί ί (dl)-og (1)-forbindelserne med formlen (XI) er nyttige som antiinflam- i matoriske midler, analgetiske midler, blodpladeaggregationsinhibi- 1 torer, fibrinolytiske midler og som gla.tmuskelafslappelsesmidler. !. The 8 (dl) and (1) compounds of formula (XI) are useful as antiinflammatory agents, analgesics, platelet aggregation inhibitors, fibrinolytic agents, and as smooth muscle relaxants. !

Disse forbindelser kan anvendes både profylaktisk og terapeutisk.These compounds can be used both prophylactically and therapeutically.

5 Produkterne, som indeholder disse forbindelser er således nyttige ved behandlingen og elimineringen af inflammation, såsom betændel-sestilstande i det muskulære skeletsystem, skeletled og andre væv, f.eks. ved behandlingen af betændelsestilstande, såsom rheumatisme, konkussion, laceration, arthritis, benbrud, posttraumatiske til-10 stande og gigt. I de tilfælde, hvor de ovennævnte tilstande omfatter smerte og pyreksi i forhindelse med inflammation, er de foreliggende forbindelser nyttige til at lindre disse tilstande såvel som inflammationen.Thus, the products containing these compounds are useful in the treatment and elimination of inflammation, such as inflammatory conditions in the muscular skeletal system, skeletal joints and other tissues, e.g. in the treatment of inflammatory conditions such as rheumatism, concussion, laceration, arthritis, fractures, post-traumatic conditions and arthritis. In cases where the above conditions include pain and pyrexia in the prevention of inflammation, the present compounds are useful in alleviating these conditions as well as the inflammation.

15 Den foretrukne administrationsmåde i forbindelse med de oyenfor he-skrevne tilstande er den orale, idet der anvendes en passende daglig dosismængde, der kan justeres i overensstemmelse med lidelsens karakter og omfang. Der anvendes en daglig dosis fra 25 mg til 500 mg af den nævnte aktive forbindelse, De fleste lidelser reagerer 20 på en behandling, som omfatter en dosismængde af størrelsesordenen 0,5 mg til 6. mg pr. kg legemsvægt pr. dag.The preferred mode of administration for the above-described conditions is the oral one, using an appropriate daily dose amount that can be adjusted according to the nature and extent of the disorder. A daily dose of 25 mg to 500 mg of said active compound is used. Most disorders respond to a treatment comprising a dose amount of the order of 0.5 mg to 6 mg per day. kg body weight per day.

De ifølge opfindelsen fremstillede forbindelser er som beskrevet ovenfor også uteringlatmuskelafslappelsesmidler og således nyttige 25 som midler til at opretholde graviditet hos gravide kvinder og drægtige pattedyr til gavn for moder og/eller foster, indtil af-sluttelse af graviditeten fra et medicinsk synspunkt findes gun- i stigt eller mere gunstigt for moderen og/eller fosteret, 30 De følgende fremstillingsmetoder og eksempler illustrerer henholdsvis fremstillingen af udgangsmaterialer eller mellemprodukter på vej til i udgangsmaterialer for fremgangsmåden ifølge opfindelsen og fremgangsmåden ifølge opfindelsen. Alle blandingsforhold, der anvendes med ! hensyn til væsker, referer til volumenforhold. Hvor det er nødven-35 digt, gentages eksempler for at fremstille yderligere materiale til efterfølgende eksempler, og med mindre andet er anført gennemføres reaktionerne ved stuetemperatur (20-30°C).The compounds of the invention, as described above, are also uterine muscle relaxants and thus useful as agents for maintaining pregnancy in pregnant women and pregnant mammals for the benefit of the mother and / or fetus until termination of pregnancy from a medical point of view is found. The following manufacturing methods and examples illustrate, respectively, the preparation of starting materials or intermediates en route to starting materials for the process of the invention and the process of the invention. All mixing conditions used with! for liquids, refer to volume ratio. Where necessary, examples are repeated to prepare additional material for subsequent examples, and unless otherwise stated, the reactions are carried out at room temperature (20-30 ° C).

9 DK 151886B9 DK 151886B

Fremstillingsmetode 1Preparation method 1

En 250 ml 3-halset, rundbundet kolbe indeholdende en magnetisk omrø-restav og forsynet med calciumchloridfyldt tørrerør forbindes direkte (via én af de udvendige halse) ved hjælp af et forlagsnæb og en kort (3") vandsvaler til acetalpyrolyseapparatet. Dette sidstnævnte appa-5 rat består af en 100 ml rundbundet kolbe (forud fyldt med 15,6 g oxal= syredihydrat og 11,82 g bromacetaldehyddiethylacetal, fremstillet af vinylacetat som beskrevet af P.Z. Bedoukian, J. Am. Chem. Soc. 66, 651 (1944)) med en 6" Vigreux-søjle i toppen forsynet med et termometer forbundet til ovennævnte svaler.A 250 ml 3-necked, round bottom flask containing a magnetic stirring rod and fitted with calcium chloride-filled drying tube is connected directly (via one of the external necks) by means of a publishing beaker and a short (3 ") water cooler to the acetal pyrolysis apparatus. 5 rat consists of a 100 ml round bottom flask (pre-loaded with 15.6 g of oxal = acid dihydrate and 11.82 g of bromoacetaldehyde diethyl acetal, prepared from vinyl acetate as described by PZ Bedoukian, J. Am. Chem. Soc. 66, 651 (1944) ) with a 6 "Vigreux column at the top provided with a thermometer connected to the above swallow.

1010

Den 3-halsede kolbe forsynes med 3,36 g ethanolamin afkølet i et isbad til 0-10°C og behandles dråbevis under omrøring med 8,7 g dime-thyl-1,3-acetonedicarboxylat. Methyl-3-carbomethoxymethyl-3(21-hy= droxyethyl)aminoacrylat (III) dannes straks. Efter endt tilsætning 15 fjernes isbadet, og 100 ml tør acetonitril tilsættes. Apparatets py-rolysedel anbringes i et oliebad, og badets temperatur hæves til 150-160°C. Bromacetaldehydopløsningen, der dannes, destilleres (kogepunkt 80-83°C/580 mm Hg) direkte til den magnetisk omrørte opløsning af vinylaminen (ill). Når destillationstemperaturen falder under 20 80°C afbrydes pyrolyseapparatet, og i stedet anbringes en tilbage svaler forsynet med et tørrerør indeholdende calciumchlorid. Opløsningen opvarmes til tilbagesvalingstemperaturen i 1 time, opløsningsmidlet fjernes under reduceret tryk, og derpå sættes 200 ml methanol og 20 g silicagel til resten. Denne blanding inddampes til tørhed i 25 vakuum og anbringes i toppen af en søjle af 200 g silicagel pakket i hexan. Søjlen elueres så med hexan/ethylacetat (80:20; 500 ml) og hexan/ethylacetat (1:1; 9 x 500 ml). Fraktioner 2 og 3 indeholder mindre polære urenheder og dimethyl-l,3-acetonedicarboxylat. Fraktionerne 4-8 giver 4,1 g methyl-N-(2-hydroxyethyl)-3-carbomethoxypyr= 30 rol-2-acetat (IV, R = H), som efter omkrystallisation fra ether/hexan har et smeltepunkt på 52-54°C.The 3-neck flask is charged with 3.36 g of ethanolamine cooled in an ice bath to 0-10 ° C and treated dropwise with stirring with 8.7 g of dimethyl-1,3-acetone dicarboxylate. Methyl 3-carbomethoxymethyl-3 (21-hydroxyethyl) aminoacrylate (III) is formed immediately. After completion of addition 15, the ice bath is removed and 100 ml of dry acetonitrile is added. The pyrolysis part of the apparatus is placed in an oil bath and the temperature of the bath is raised to 150-160 ° C. The bromoacetaldehyde solution formed is distilled (boiling point 80-83 ° C / 580 mm Hg) directly to the magnetically stirred solution of the vinylamine (ill). When the distillation temperature falls below 80 ° C, the pyrolysis apparatus is discontinued and a back swallower fitted with a drying tube containing calcium chloride is replaced. The solution is heated to reflux for 1 hour, the solvent is removed under reduced pressure and then 200 ml of methanol and 20 g of silica gel are added to the residue. This mixture is evaporated to dryness in vacuo and placed on top of a column of 200 g of silica gel packed in hexane. The column is then eluted with hexane / ethyl acetate (80:20; 500 mL) and hexane / ethyl acetate (1: 1; 9 x 500 mL). Fractions 2 and 3 contain minor polar impurities and dimethyl-1,3-acetone dicarboxylate. Fractions 4-8 give 4.1 g of methyl N- (2-hydroxyethyl) -3-carbomethoxypyr = 30-roll-2-acetate (IV, R = H) which, after recrystallization from ether / hexane, has a melting point of 52%. 54 ° C.

Frems ti1lingsmetode 2Forward method 2

35 Til en omrørt opløsning af 4,1 g methyl-N-(2-hydroxyethyl)-3-carbo= methoxypyrrol-2-acetat i 35 ml tør dichlormethan afkølet til -10°C sættes 2,65 ml triethylamin, og derefter tildryppes 1,46 ml methan= sulfonylchlorid, idet reaktionsblandingens temperatur holdes på -10°CTo a stirred solution of 4.1 g of methyl N- (2-hydroxyethyl) -3-carboxy methoxypyrrole-2-acetate in 35 ml of dry dichloromethane cooled to -10 ° C is added 2.65 ml of triethylamine and then added dropwise. 1.46 ml of methane = sulfonyl chloride keeping the temperature of the reaction mixture at -10 ° C

10 DK 151886 BDK 151886 B

til -5°C. Reaktionsforløbet følges ved hjælp af en tyndtlagskromato-grafisk analyse under anvendelse af chloroform/acetone (90:10). Når reaktionen viser sig at være fuldstændig (ca. 30 minutter efter endt meihansulfonylchloridiilsæining) tilsættes 10 ffll vand langsomt. Døn 5 organiske fase skilles fra, vaskes med vand (3 x 30 ml), tørres over natriumsulfat og inddampes under reduceret tryk. Krystallisation af resten fra dichlormethan/hexan giver 4,75 g (77,7%) methyl-N-(2-mesyl= oxyethyl)-3-carbomethoxypyrrol-2-acetat (V, R = H), smeltepunkt 99-101°C.to -5 ° C. The reaction is followed by a thin layer chromatographic analysis using chloroform / acetone (90:10). When the reaction turns out to be complete (about 30 minutes after the end of methanesulfonyl chloride seeding), add 10 to 10 times water slowly. Drain 5 organic phases are separated, washed with water (3 x 30 ml), dried over sodium sulfate and evaporated under reduced pressure. Crystallization of the residue from dichloromethane / hexane gives 4.75 g (77.7%) of methyl N- (2-mesyl = oxyethyl) -3-carbomethoxypyrrole-2-acetate (V, R = H), m.p. 99-101 ° C.

1010

Fr ems t i ll i ng sine t o d e 3Forward t o ll i ng its t o d e 3

En opløsning af 785 mg methyl-N-(2-mesyloxyethyl)-3-carbomethoxypyr-rol-2-acetat og 1,83 g natriumjodid i 10 ml acetonitril tilbagesvales 15 il time. Den afkølede reaktionsblanding inddampes til tørhed under reduceret tryk, og resten sønderdeles med vand. Det uopløselige materiale skilles fra ved filtrering og lufttørres. Herved fås 840 mg (97%) methyl-N-(2-jodethyl)-3-carbomethoxypyrrol-2-acetat (VI, R = H), smeltepunkt 137-138°C.A solution of 785 mg of methyl N- (2-mesyloxyethyl) -3-carbomethoxypyrrole-2-acetate and 1.83 g of sodium iodide in 10 ml of acetonitrile is refluxed for 15 l. The cooled reaction mixture is evaporated to dryness under reduced pressure and the residue is decomposed with water. The insoluble material is separated by filtration and air dried. There is thus obtained 840 mg (97%) of methyl N- (2-iodoethyl) -3-carbomethoxypyrrole-2-acetate (VI, R = H), mp 137-138 ° C.

20 F r ems til1ing smetode 4 '20 For Reaming Method 4 '

En opløsning af 1 g methyl-N-(2-jodethyl)-3-carbomethoxypyrrol-2-ace= | tat i 5 ml tør dimethylformamid omrøres under en argonatmosfære med | 137 mg 50% natriumhydrid i mineralolie. Reaktionsblandingen holdes | Z O ( i 30 minutter ved stuetemperatur og afkøles derpå hurtigt med 100 ml i vand. Produktet ekstraheres med ethylacetat (3 x 50 ml), de forenede j ekstrakter vaskes med vand, tørres over magnesiumsulfat og inddampes j til tørhed. Kromatografi af resten på 20 g silicagel, idet der anven-! 3Q des hexan/ethylacetat (4:1) som elueringsmiddel, giver 500 mg (80%) j dimethyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrol-l,7-dicarboxylat (VII, j R = H), smeltepunkt 70-71°C. i i jA solution of 1 g of methyl N- (2-iodoethyl) -3-carbomethoxypyrrole-2-ace = | tat in 5 ml of dry dimethylformamide is stirred under an argon atmosphere with | 137 mg 50% sodium hydride in mineral oil. The reaction mixture is kept | ZO (for 30 minutes at room temperature and then rapidly cooled with 100 ml in water. The product is extracted with ethyl acetate (3 x 50 ml), the combined extracts are washed with water, dried over magnesium sulfate and evaporated to dryness. g of silica gel, using 3Q of hexane / ethyl acetate (4: 1) as eluent, gives 500 mg (80%) of dimethyl-1,2-dihydro-3H-pyrrolo [1,2-a] pyrrole-1 7-dicarboxylate (VII, R = H), mp 70-71 ° C.

En opløsning af 1,80 g dimethyl-l,2-dihydro-3H-pyrrolo[l,2-a]pyrrol-35 1,7-dicarboxylat i 20 ml methanol behandles med en opløsning af 4,48 g kaliumhydroxid i 20 ml vand, og reaktionsblandingen tilbagesvales i 6 timer. Den afkølede opløsning inddampes til tørhed, og resten behandles med 50 ml mættet natriumchloridopløsning. Den resulterende opløsning syrnes med 6N saltsyre og ekstraheres med ethylacetat (3 x 4Q 50 ml). De forenede ekstrakter tørres over magnesiumsulfat og ind-A solution of 1.80 g of dimethyl-1,2-dihydro-3H-pyrrolo [1,2-a] pyrrole-1,7-dicarboxylate in 20 ml of methanol is treated with a solution of 4.48 g of potassium hydroxide in 20 ml. water and the reaction mixture is refluxed for 6 hours. The cooled solution is evaporated to dryness and the residue is treated with 50 ml of saturated sodium chloride solution. The resulting solution is acidified with 6N hydrochloric acid and extracted with ethyl acetate (3 x 4Q 50 mL). The combined extracts are dried over magnesium sulfate and concentrated by evaporation.

11 DK 151886 B11 DK 151886 B

dampes til tørhed under reduceret tryk. Herved fås 1,51 g (95%) 1,2-dihydro-3H-pyrrolo[l,2-a]pyrrol-l,7-dicarboxylsyre (VIII, R = H), smeltepunkt 220°C under dekomponering.steam to dryness under reduced pressure. There is thus obtained 1.51 g (95%) of 1,2-dihydro-3H-pyrrolo [1,2-a] pyrrole-1,7-dicarboxylic acid (VIII, R = H), m.p. 220 ° C during decomposition.

Fremstillingsmetode 5 5 En opløsning af 1,34 g 1,2-dihydro-3H-pyrrolo[l,2-a]pyrrol-l,7-dicarb= oxylsyre i 50 ml isopropanol, afkølet i et isbad, mættes med hydrogen= chloridgas, idet reaktionsblandingens temperatur holdes under 50°C. Isbadet fjernes derpå, og reaktionsblandingen omrøres i 1 1/2 time ved stuetemperatur og inddampes til tørhed under reduceret tryk. 10 ml 10 benzen sættes til resten, og opløsningen inddampes igen under vakuum, idet denne proces gentages ialt tre gange for fuldstændigt at fjerne hydrogenchloridoverskud. Således fås 1,58 g (96%) isopropyl-l,2-dihy= dro-3H-pyrrolo[l,2-a]pyrrol-l-carboxylat-7-carboxylsyre (IX, R = H, p R = iso-C^Hy), som efter omkrystallisation fra methanol/ethylacetat 15 har et smeltepunkt på 144-145°C.Preparation Method 5 A solution of 1.24 g of 1,2-dihydro-3H-pyrrolo [1,2-a] pyrrole-1,7-dicarboxylic acid in 50 ml of isopropanol, cooled in an ice bath, is saturated with hydrogen = chloride gas keeping the temperature of the reaction mixture below 50 ° C. The ice bath is then removed and the reaction mixture is stirred for 1 1/2 hours at room temperature and evaporated to dryness under reduced pressure. 10 ml of 10 benzene is added to the residue and the solution is evaporated again under vacuum, repeating this process a total of three times to completely remove excess hydrogen chloride. Thus, 1.58 g (96%) of isopropyl-1,2-dihydro-3H-pyrrolo [1,2-a] pyrrole-1-carboxylate-7-carboxylic acid (IX, R = H, p R = iso -C1 Hy) which, after recrystallization from methanol / ethyl acetate 15, has a melting point of 144-145 ° C.

På tilsvarende måde, men under anvendelse af methanol, ethanol, propanol og n-butanol i stedet for isopropanol ved den ovennævnte fremgangsmåde, fås henholdsvis følgende udgangsmaterialer: O Π methyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrol-l-carboxylat-7-carboxylsyre, ethyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrol-l-carboxylat-7-carboxylsyre, propyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrol-l-carboxylat-7-carboxylsyre og p c butyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrol-l-carboxylat-7-carboxylsyre.Similarly, but using methanol, ethanol, propanol and n-butanol instead of isopropanol by the above process, the following starting materials are obtained, respectively: O Π methyl-1,2-dihydro-3H-pyrrolo [1,2-a ] pyrrole-1-carboxylate-7-carboxylic acid, ethyl 1,2-dihydro-3H-pyrrolo [1,2-a] pyrrole-1-carboxylate-7-carboxylic acid, propyl-1,2-dihydro-3H-pyrrolo [1,2-a] pyrrole-1-carboxylate-7-carboxylic acid and pc butyl-1,2-dihydro-3H-pyrrolo [1,2-a] pyrrole-1-carboxylate-7-carboxylic acid.

F r em s t i11i ngsmeto de 6 1,054 g isopropyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrol~l-carboxylat-7-30 carboxylsyre opvarmes til 240-250°C i en tør 10 ml rundbundet kolbe, idet reaktionsproduktet destilleres direkte fra reaktionsbeholderen.For example, the method of measuring 6 1,054 g of isopropyl-1,2-dihydro-3H-pyrrolo [1,2-a] pyrrole-1-carboxylate-7-30 carboxylic acid is heated to 240-250 ° C in a dry 10 ml. round bottom flask, the reaction product being distilled directly from the reaction vessel.

På denne måde fås 745 mg (87%) isopropyl-1,2-dihydro-3H-pyrrolo[l,2-a] p pyrrol-l-carboxylat (X, R = H, R = iso-C^Hy), en lysegul olie med følgende fysiske konstanter: U.V. : 215 nm (e 6020); I.R. : V^^p3 35 1725 cm -1; N.M.R. : 1,22 (d, J = 7Hz, 6H), 2,40-2,90 (m, 2H), 3,60-4,20 (m, 2H), 4,65-5,2 (m, IH), 5,73-5,92 (m, IH), 6,10 (t, J = 3Hz, IH), 6,43-6,53 ppm. (m, IH).In this way, 745 mg (87%) of isopropyl-1,2-dihydro-3H-pyrrolo [1,2-a] p pyrrol-1-carboxylate (X, R = H, R = iso-C a pale yellow oil with the following physical constants: UV : 215 nm (e 6020); I.R. : V ^^ p3 1725 cm -1; N.M.R. : 1.22 (d, J = 7Hz, 6H), 2.40-2.90 (m, 2H), 3.60-4.20 (m, 2H), 4.65-5.2 (m, 1H), 5.73-5.92 (m, 1H), 6.10 (t, J = 3Hz, 1H), 6.43-6.53 ppm. (m, 1H).

12 DK 151886 B12 DK 151886 B

Fremstillingsmetode 7Method of preparation 7

En 100 ml 3-halset, rundmundet kolbe forsynet med en svaler, nitrogentilledningsrør og en gasbobler er forsynet med 5,0 g isopropyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrol-l-carboxylat-7-carboxylsyre. Appara-5 tet gennemblæses med nitrogen, og nitrogenstrømmen standses derpå. Apparatet neddykkes i et oliebad opvarmet til 270°C, og reaktionen følges ved hjælp af carbondioxidudviklingens hastighed (gasbobler) og ved tyndtlagskromatografi på silicagel under anvendelse af benzen/di= oxan/eddikesyre (90:10:1) som fremkaldermiddel. Efter 45 minutters 10 forløb er reaktionen forløbet næsten fuldstændigt. Efter 1 times forløb fjernes beholderen fra oliebadet, og reaktionskolbens indhold overføres til en rundbundet kolbe med 500 ml acetone. Opløsningsmidlet fjernes under reduceret tryk, og resten renses ved søjlekromatografi på 100 g silicagel. Fraktionerne elueret med hexan/benzen (70: 15 30) og hexan/benzen (50:50) giver 2,77 g (68%) isopropyl-l,2-dihydro- 3H-pyrrolo[l,2-a]pyrrol-l-carboxylat (X, R = H, = iso-C-^Hy), en olie hvis fysiske konstanter er identiske med de, der blev opnået i fremstillingsmetode 6.A 100 ml 3-necked, round mouth flask is provided with a cooler, nitrogen supply tube and a gas bubbler is provided with 5.0 g of isopropyl-1,2-dihydro-3H-pyrrolo [1,2-a] pyrrole-1-carboxylate-7 carboxylic acid. The apparatus is purged with nitrogen and the nitrogen flow is then stopped. The apparatus is immersed in an oil bath heated to 270 ° C and the reaction is monitored by the rate of carbon dioxide evolution (gas bubbles) and by thin layer chromatography on silica gel using benzene / di = oxane / acetic acid (90: 10: 1) as the developing agent. After 45 minutes of 10 minutes the reaction is almost complete. After 1 hour, the vessel is removed from the oil bath and the contents of the reaction flask are transferred to a round bottom flask with 500 ml of acetone. The solvent is removed under reduced pressure and the residue is purified by column chromatography on 100 g of silica gel. The fractions eluted with hexane / benzene (70: 30) and hexane / benzene (50:50) give 2.77 g (68%) of isopropyl-1,2-dihydro-3H-pyrrolo [1,2-a] pyrrole. 1-carboxylate (X, R = H, = iso-C- Hy), an oil whose physical constants are identical to those obtained in Preparation Method 6.

20 Fremstillingsmetode 8Preparation Method 8

En 250 ml 3-halset, rundbundet kolbe med magnetisk omrørestav og forsynet med et calciumchloridfyldt tørrerør er forsynet med 3,56 g ethanolamin, afkølet i et isbad til 0-10°C, og behandles dråbevis un-der omrøring med 8,7 g dimethyl-l,3-acetonedicarboxylat. Methyl-3-carbomethoxymethyl-3-(2’-hydroxyethyl)-aminoacrylat (III) dannes straks. Efter endt tilsætning fjernes isbadet, og 80 ml tør acetoni- j tril tilsættes. Reaktionsblandingen behandles derpå dråbevis med 1 6,75 g bromacetaldehyd i 20 ml acetonitril,og derefter opvarmes under tilbagesvaling i 2 timer. Opløsningsmidlet fjernes så under reduceret tryk, og 200 ml methanol og 20 g silicagel sættes til resten. Denne blanding inddampes til tørhed i vakuum og anbringes i toppen af en søjle af 200 g silicagel pakket i hexan, idet søjlen blev elueret med blandinger af hexan og ethylacetat. De med hexan/ethylacetat (1:1) eluerede fraktioner gav methyl-N-(2-hydroxyethyl)-3-carbomethoxypyr= 3 5 rol-2-acetat (IV, R = H), som er identisk med det i fremstillingsmetode 1 opnåede produkt.A 250 ml 3-necked, round bottom flask with magnetic stir bar and fitted with a calcium chloride-filled drying tube is provided with 3.56 g of ethanolamine, cooled in an ice bath to 0-10 ° C and treated dropwise with stirring with 8.7 g dimethyl-l, 3-acetonedicarboxylate. Methyl 3-carbomethoxymethyl-3- (2'-hydroxyethyl) aminoacrylate (III) is formed immediately. After the addition is complete, remove the ice bath and add 80 ml of dry acetonitrile. The reaction mixture is then treated dropwise with 1.75 g of bromoacetaldehyde in 20 ml of acetonitrile, and then refluxed for 2 hours. The solvent is then removed under reduced pressure and 200 ml of methanol and 20 g of silica gel are added to the residue. This mixture is evaporated to dryness in vacuo and placed on top of a column of 200 g of silica gel packed in hexane, eluting with the mixture of hexane and ethyl acetate. The fractions eluted with hexane / ethyl acetate (1: 1) gave methyl N- (2-hydroxyethyl) -3-carbomethoxypyr = 35-2-acetate (IV, R = H) identical to that of Preparation Method 1 product obtained.

1'" 131 '"13

DK 151886 BDK 151886 B

Fremstillingsmetode 9Preparation Method 9

Til en opløsning af 6 ml ethanolamin i 5 ml vand sættes 1,74 g dime-thyl-l,3-acetonedicarboxylat. Den resulterende blanding afkøles hurtigt til -10°C og behandles dråbevis i løbet af en periode på 15 minutter under omrøring med 1,67 ml 1-bromacetone, medens reaktionsblan-5 dingens temperatur blev holdt på højst 40°C. Efter endt tilsætning omrøres den mørke reaktionsblanding i endnu 1 time ved stuetemperatur og hældes derpå.i en blanding af saltsyre og is, mættet med fast na-triumchlorid og ekstraheret med ethylacetat (3 x 100 ml). De forene.·*· de organiske ekstrakter vaskes med koldt vand til neutral reaktion, 10 tørres med vandfri natriumsulfat og inddampes til tørhed under reduceret tryk. Kromatografi af resten på 30 g silicagel under anvendelse af hexan:ethylacetat (70:30) som elueringsmiddel giver 890 mg krystallinsk methyl-N-(2-hydroxyethyl)-3-carbomethoxy-4-methylpyrrol-2-acetat, som efter omkrystallisation fra methylenchlorid/hexan smelter ved 15 78°C og har følgende analyse:To a solution of 6 ml of ethanolamine in 5 ml of water is added 1.74 g of dimethyl-1,3-acetone dicarboxylate. The resulting mixture is rapidly cooled to -10 ° C and treated dropwise over a period of 15 minutes with stirring with 1.67 ml of 1-bromoacetone while maintaining the temperature of the reaction mixture at a maximum of 40 ° C. After completion of the addition, the dark reaction mixture is stirred for an additional hour at room temperature and then poured into a mixture of hydrochloric acid and ice, saturated with solid sodium chloride and extracted with ethyl acetate (3 x 100 ml). The combined extracts are washed with cold water for neutral reaction, dried with anhydrous sodium sulfate and evaporated to dryness under reduced pressure. Chromatography the residue on 30 g of silica gel using hexane: ethyl acetate (70:30) as the eluent to give 890 mg of crystalline methyl N- (2-hydroxyethyl) -3-carbomethoxy-4-methylpyrrole-2-acetate, which after recrystallization from methylene chloride / hexane melts at 78 ° C and has the following analysis:

Beregnet for ^2^17^0^: C 56,45, H 6,71Calcd for C 21 H 17 O: C 56.45, H 6.71

Fundet: C 56,41, H 6,73.Found: C 56.41, H 6.73.

20 På tilsvarende måde, men under anvendelse af en støkiometrisk ækvivalent mængde l-brom-2-butanon i stedet for 1-bromacetone fås: methyl-N- (2-hydroxyethyl )*3^carbcmethoxy-4-ethylpyrrol-2-acetat, smp. 61-62°C0 25Similarly, but using a stoichiometric equivalent amount of 1-bromo-2-butanone instead of 1-bromoacetone, there is obtained: methyl N- (2-hydroxyethyl) * 3 ^ carbomethoxy-4-ethylpyrrole-2-acetate, mp. 61-62 ° C

Fremstillingsmetode 10 2g Ved at følge fremstillingsmetoderne 2, 3, 4, 5 og 7 omdannes methyl-N- (2-hydroxyethyl)-3-carbomethoxy-4-methylpyrrol-2-acetat (IV, r = CH^) successivt til: methyl-N- (2-mesyloxyethyl) -3-carbomethoxy-4-methylpyrrol-2-acetat, smp. 81°C, methyl-N-(2-jodethyl)-3-carbomethoxy-4-methylpyrrol-2-acetat, smp. 103°C,Preparation Method 10 2g Following Methods 2, 3, 4, 5 and 7, methyl N- (2-hydroxyethyl) -3-carbomethoxy-4-methylpyrrole-2-acetate (IV, r = CH 2) is successively converted to: methyl -N- (2-mesyloxyethyl) -3-carbomethoxy-4-methylpyrrole-2-acetate, m.p. 81 ° C, methyl N- (2-iodoethyl) -3-carbomethoxy-4-methylpyrrole-2-acetate, m.p. 103 ° C,

dimethyl-l,2-dihydro-6-methyl-3H- pyrrolo[1,2-a]pyrrol-1,7-dicarboxylat, smp. 71°Cdimethyl-1,2-dihydro-6-methyl-3H-pyrrolo [1,2-a] pyrrole-1,7-dicarboxylate, m.p. 71 ° C

1,2-dihydro-6-methyl-3H-pyrrolo[ 1,2-a]pyrrol-1,7-dicarboxylsyre, smp. 200-203°C, 35 141,2-dihydro-6-methyl-3H-pyrrolo [1,2-a] pyrrole-1,7-dicarboxylic acid, m.p. 200-203 ° C, 14

DK 151886BDK 151886B

isopropyl-1,2-dihydro-6-methyl-3H-pyrrolo[1,2-a]pyrrol-l-carboxylat- 7-carboxylsyre, smp. 160°C og i sopropyl-1,2-dihydro-6-methyl-3H-pyrrolo[1,2-a]pyrrol-l-carboxylat (X, R = CH^, = iso-C^Hy)* olie.isopropyl-1,2-dihydro-6-methyl-3H-pyrrolo [1,2-a] pyrrole-1-carboxylate-7-carboxylic acid, m.p. 160 ° C and in sopropyl-1,2-dihydro-6-methyl-3H-pyrrolo [1,2-a] pyrrole-1-carboxylate (X, R = CH 2, = iso-C 2 Hy) * oil.

Fremstillingsmetode 11 D 1 710 mg af en 50% suspension af natriumhydrid i mineralolie vaskes med vandfri hexan under en nitrogenatmosfære og suspenderes så i 50 ml dimethylformamid. Suspensionen afkøles til -5°C, og 4,5 g methyl-N-(2-mesyloxymethyl)-3-carbomethoxypyrrol-2-acetat tilsættes, idet reak-10 tionsblandingen omrøres ved -5°C - 0°C i 1 time. Den hældes derpå i isafkølet natriumchloridopløsning og ekstraheres adskillige gange med benzen. De forenede ekstrakter vaskes med vand, tørres og inddampes til tørhed under reduceret tryk. Den faste rest krystalliseres fra ether, og således fås dimethyl-l,2-dihydro-3H-pyrrolo[l,2-a]pyrrol-l,7-15 dicarboxylat (VII, R = H), der er identisk med det i fremstillingsmetode 4 opnåede produkt med smp. 70-71°C.Preparation Method 11 D 1 710 mg of a 50% suspension of sodium hydride in mineral oil is washed with anhydrous hexane under a nitrogen atmosphere and then suspended in 50 ml of dimethylformamide. The suspension is cooled to -5 ° C and 4.5 g of methyl N- (2-mesyloxymethyl) -3-carbomethoxypyrrole-2-acetate is added, stirring the reaction mixture at -5 ° C - 0 ° C for 1 hour. . It is then poured into ice-cooled sodium chloride solution and extracted several times with benzene. The combined extracts are washed with water, dried and evaporated to dryness under reduced pressure. The solid residue is crystallized from ether to give dimethyl-1,2-dihydro-3H-pyrrolo [1,2-a] pyrrole-1,7-15 dicarboxylate (VII, R = H) identical to that of Preparation method 4 obtained product with m.p. 70-71 ° C.

Fremstillingsmetode 12 20 Til en 250 ml 3-halset, rundbundet kolbe forsynet med en nitrogentilog fraledningsventil, en magnetisk omrørestav og en trykudlignet tilsætningstragt indeholdende 10,08 g ethanolamin, tildryppes under omrøring 26,1 g dimethyl-l,3-acetonedicarboxylat i løbet af en periode 25 på 30 minutter, medens temperaturen holdes under 30°C. Det dannede methyl-3-carbomethoxymethyl-3-(2’-hydroxyethyl)-aminoacrylat (III) fortyndes med 20 ml acetonitril og chloracetaldehyd, forud fremstillet ved opvarmning af en blanding af 27,4 g chloracetaldehyddiethylacetal med 46,8 g oxalsyredihydrat ved 150-l60°C, tilsættes under omrøring i 3q løbet af en 2 minutters periode. Reaktionsblandingen tilbagesvales i 5-10 minutter, hvorefter reaktionen ved hjælp af tyndtlagskromatogra-fisk analyse under anvendelse af acetone/chloroform (10:90) som elue-ringsmiddel viser sig at være forløbet fuldstændig. Opløsningsmidlet fjernes under reduceret tryk, og til resten sættes 250 ml benzen og 35 250 ml heptan, og destillation gennemføres derpå under reduceret tryk.Preparation Method 12 To a 250 ml 3-necked, round bottom flask equipped with a nitrogen addition and relief valve, a magnetic stir bar and a pressure equalized addition funnel containing 10.08 g of ethanolamine are added while stirring 26.1 g of dimethyl-1,3-acetonedicarboxylate. for a period of 25 minutes, while keeping the temperature below 30 ° C. The resulting methyl 3-carbomethoxymethyl-3- (2'-hydroxyethyl) aminoacrylate (III) is diluted with 20 ml of acetonitrile and chloroacetaldehyde, pre-prepared by heating a mixture of 27.4g of chloroacetaldehyde diethylacetal with 46.8g of oxalic acid dihydrate at 150 -60 ° C, is added with stirring for 3q over a 2 minute period. The reaction mixture is refluxed for 5-10 minutes, after which the reaction by thin layer chromatographic analysis using acetone / chloroform (10:90) as the eluent is found to be complete. The solvent is removed under reduced pressure, and to the residue are added 250 ml of benzene and 250 ml of heptane, and distillation is then carried out under reduced pressure.

Den olieagtige rest, der bliver tilbage efter destillationen suspenderes i 50 ml methylenchlorid, og hertil sættes 20 g silicagel. Me- 15The oily residue remaining after distillation is suspended in 50 ml of methylene chloride and to this is added 20 g of silica gel. Me- 15

DK 151886 BDK 151886 B

thylenchloridblandingen hældes på en søjle indeholdende 200 g silica= gel lavet i ethylacetatrhexan (20:80). Søjlen elueres først med 6 liter ethylacetatihexan (20:80) og så med 4 liter ethylacetat:hexan (50:50). De med ethylacetat:hexan (50:50) eluerede fraktioner forenes 5 og koncentreres til opnåelse af 12,8 g af en olie, som sønderdeles med 20 ml petroleumsether (30-60°C) efterfulgt af fjernelse af opløsningsmidlet under reduceret tryk til fremstilling af 11,89 g (32,9% af det teoretiske udbytte) methyl-N-(2,-hydroxyethyl)-3-carbomethoxy= pyrrol-2-acetat (IV, R = H) med et smeltepunkt på 51-54°C, det samme 10 produkt som blev opnået ved fremstillingsmetode 1.The thylene chloride mixture is poured onto a column containing 200 g of silica gel made in ethyl acetate trhexane (20:80). The column is first eluted with 6 liters of ethyl acetate hexane (20:80) and then with 4 liters of ethyl acetate: hexane (50:50). The fractions eluted with ethyl acetate: hexane (50:50) are combined and concentrated to give 12.8 g of an oil which is decomposed with 20 ml of petroleum ether (30-60 ° C) followed by removal of the solvent under reduced pressure to prepare of 11.89 g (32.9% of theory) of methyl N- (2, -hydroxyethyl) -3-carbomethoxy = pyrrole-2-acetate (IV, R = H), m.p. 51-54 ° C, the same product obtained by Preparation Method 1.

Eksempel 1Example 1

En opløsning af 179 mg N,N-dimethyl-p-toluamid og 0,11 ml phosphoroxy= chlorid i 2 ml 1,2-dichlorethan tilbagesvales i 30 minutter. Til denne opløsning sættes en opløsning af 193 mg isopropyl-l,2-dihydro-3H-pyrrolo[1,2-a]pyrrol-l-carboxylat i 2 ml 1,2-dichlorethan. Reaktionsblandingen tilbagesvales under en argonatmosfære i 8 timer, behandles med 405 mg natriumacetat og tilbagesvales i yderligere 5 timer. Den resulterende blanding inddampes så til tørhed, og resten kromatogra-feres på 12 g silicagel, idet der elueres med hexan/ethylacetat (3:1). Således fås 208 mg (66%) isopropyl-5-p-toluoyl-l,2-dihydro-3H-pyrrolo 20·' [l,2-a]pyrrol-l-carboxylat (XI, R = H, R1 = p-CH^, R2 = iso-C^H^), en olie med følgende fysiske konstanter: U.V.256, 312 nm, (e 8700, 19500); 1735, 1620, 1605 cm"1; N.M.R. : 6¾¾¾ 1,23 (d, J = 7Hz, 6h), 2,38 (s, 3H), 2,5-3,0 (m, 2H), 3,75-4,10 (m, IH), 4,2-4,60 (m, 2H), 4,85-5,20 (m, IH), 5,95 (d, J = 4Hz, IH), 6,70 (d, J = 4Hz, 25 IH), 7,10 (d, J = 8Hz, 2H), 7,60 ppm. (d, J = 8Hz, 2H).A solution of 179 mg of N, N-dimethyl-p-toluamide and 0.11 ml of phosphorus oxychloride in 2 ml of 1,2-dichloroethane is refluxed for 30 minutes. To this solution is added a solution of 193 mg of isopropyl-1,2-dihydro-3H-pyrrolo [1,2-a] pyrrole-1-carboxylate in 2 ml of 1,2-dichloroethane. The reaction mixture is refluxed under an argon atmosphere for 8 hours, treated with 405 mg of sodium acetate and refluxed for an additional 5 hours. The resulting mixture is then evaporated to dryness and the residue is chromatographed on 12 g of silica gel eluting with hexane / ethyl acetate (3: 1). Thus, 208 mg (66%) of isopropyl-5-p-toluoyl-1,2-dihydro-3H-pyrrolo 20 · [1,2-a] pyrrole-1-carboxylate (XI, R = H, R1 = p -CH₂, R2 = iso-C CH H), an oil having the following physical constants: UV256, 312 nm, (e 8700, 19500); 1735, 1620, 1605 cm -1; NMR: δ 1.23 (d, J = 7Hz, 6h), 2.38 (s, 3H), 2.5-3.0 (m, 2H), 3.75 -4.10 (m, 1H), 4.2-4.60 (m, 2H), 4.85-5.20 (m, 1H), 5.95 (d, J = 4Hz, 1H), 6 , 70 (d, J = 4Hz, 25H), 7.10 (d, J = 8Hz, 2H), 7.60 ppm (d, J = 8Hz, 2H).

Eksempel 2Example 2

Ved at følge fremgangsmåden fra eksempel 1 under anvendelse af 1,1-5 molærækvivalenter N,N-dimethylbenzamid, N,N-dimethy1-o-toluamid, 3 5 J N,N-dimethyl-m-toluamid, Γ DK 151886Β 16 Ν,N-dimethyl-p-methoxybenzamid, Ν,N-dimethyl-p-ethoxybenzamid, Ν,N-dimethy1-o-chlorbenzamid, Ν,N-dimethy1-m-ch1orbenzamid, 5 Ν,Ν-dimethyl-p-chlorbenzamid, N,N-dimethyl-p-fluorbenzamid, og N,N-dimethyl-m-ethoxybenzamid i stedet for N,N-dimethyl-p-toluamid og overvågning af reaktionsforløbet ved hjælp af tyndtlagskromatografi fås henholdsvis: isopropyl-5-benzoyl-l,2-dihydro-3H-pyrrolo[1,2-a]pyrrol-l-carboxylat, en lysegul olie med følgende fysiske konstanter: U.V.: 245, 311 nm (e 7230, 17800); I.R.: ^£^3 1735, 1620 cm"1; N.M.R.: 124 (d, 6H, (CH3)2CH), 250-3,13 (m, 2H; H-2); 3,97 (dd, IH, H-l), 4,18-4,70 (m, 2H, H-3), 5,00 (sept., IH, (CH3)2CH), 6,00 (d, IH, H-7), 15 6,86 (d, IH, H-6), 7,10-7,90 ppm. (m, 5H, phenylprotoner); M.S.: m/e 297 (M+), isopropyl-5-o-toluoyl-l,2-dihydro-3H-pyrrolo[1,2-a]pyrrol-l-carboxylat,Following the procedure of Example 1 using 1.1-5 molar equivalents N, N-dimethylbenzamide, N, N-dimethyl-o-toluamide, JN, N-dimethyl-m-toluamide, Γ DK 151886Β 16 Ν, N-dimethyl-p-methoxybenzamide, Ν, N-dimethyl-p-ethoxybenzamide, Ν, N-dimethyl-o-chlorobenzamide, Ν, N-dimethyl-m-chlorobenzamide, 5 Ν, Ν-dimethyl-p-chlorobenzamide, N , N-dimethyl-p-fluorobenzamide, and N, N-dimethyl-m-ethoxybenzamide in place of N, N-dimethyl-p-toluamide and monitoring the reaction process by thin layer chromatography are obtained respectively: isopropyl-5-benzoyl-1, 2-dihydro-3H-pyrrolo [1,2-a] pyrrole-1-carboxylate, a pale yellow oil having the following physical constants: UV: 245, 311 nm (e 7230, 17800); IR: δ 3 1735, 1620 cm "1; NMR: 124 (d, 6H, (CH3) ₂CH), 250-3.13 (m, 2H; H-2); 3.97 (dd, 1H, H1), 4.18-4.70 (m, 2H, H-3), 5.00 (sept, 1H, (CH 3) 2CH), 6.00 (d, 1H, H-7), 6 , 86 (d, 1H, H-6), 7.10-7.90 ppm (m, 5H, phenyl protons); MS: m / e 297 (M +), isopropyl-5-o-toluoyl-1,2 dihydro-3H-pyrrolo [1,2-a] pyrrole-l-carboxylate,

— QTI- QTI

en olie med følgende fysiske konstanter: U.V.: Åma|cs 252, 303 nm 20 (e 4460, 19100): 1735, 1620 cm-1; N.M.R.: 1,18 (d, 6H, (CH3)2CH), 2,28 (s, 3H-, o-CH^), 2,50-3,13 (m, 2H, H-2), 3,92 (dd, IH, H-l), 4,17-4,70 (m, 2H, H-3), 4,98 (sept. IH, (CH3)2CH), 5,92 (d, IH, H-7), 6,43 (d, IH, H-6), 6,97-7,45 ppm. (m, 4H, phenyl= protoner), 25 isopropyl-5-m-toluoyl-l,2-dihydro-3H-pyrrolo[1,2-a]pyrrol-l-carboxylat, en olie med følgende fysiske konstanter: U.V. :Amak.s 250-251, 310-312 nm (e 6460, 17400); I.R.i^S 1735, 1620 cm'1; N.M.R.: 1,25 (d, 6η, (CH3)2CH), 2,27 (s, 3H, CH3), 2,52-3,13 (m, 2H, H-2), 3,92 (dd, IH, H-l), 4,13-4,70 (m, 2H, H-3), 4,95 (sept. IH, (CH3)2CH), 30 5,95 (d, IH, H-7), 6,67 (d, IH, H-6), 7,03-7,57 ppm. (m, 4H; phenyl= protoner),an oil having the following physical constants: U.V .: Åma 25 cs, 303 nm 20 (e 4460, 19100): 1735, 1620 cm -1; NMR: 1.18 (d, 6H, (CH3) 2CH), 2.28 (s, 3H-, o -CH2), 2.50-3.13 (m, 2H, H-2), 3, 92 (dd, 1H, H1), 4.17-4.70 (m, 2H, H-3), 4.98 (Sept. 1H, (CH3) 2CH), 5.92 (d, 1H, H- 7), 6.43 (d, 1H, H-6), 6.97-7.45 ppm. (m, 4H, phenyl = protons), isopropyl-5-m-toluoyl-1,2-dihydro-3H-pyrrolo [1,2-a] pyrrole-1-carboxylate, an oil having the following physical constants: U.V. : Amak.s 250-251, 310-312 nm (e 6460, 17400); I.R.i ^ S 1735, 1620 cm -1; NMR: 1.25 (d, 6η, (CH 3) 2 CH), 2.27 (s, 3H, CH 3), 2.52-3.13 (m, 2H, H-2), 3.92 (dd, 1H, H1), 4.13-4.70 (m, 2H, H-3), 4.95 (Sept. 1H, (CH3) 2CH), 5.95 (d, 1H, H-7), 6.67 (d, 1H, H-6), 7.03-7.57 ppm. (m, 4H; phenyl = protons),

DK 151886BDK 151886B

17 isopropyl-5-p-methoxybenzoyl-l,2-dihydro-3H-pyrrolo[1,2-a]pyrrol-l-carboxylat med følgende fysiske konstanter: U.V.: 218, 270- 284 (skulder), 314 nm (e 9780, 9320, 22400); I.R. :^^3 1730, 1605 cm"1; N.M.R.: 1,24 (d, 6H, J = 6Hz; (CH3)2CH-), 5 2,50-3,10 (m, 2H; H-2), 3,78 (s, 3H; CH^O), 3,93 (dd, IH, = 6Hz, JBX = 7Hz; H-l), 4,13-4,60 (Μ, 2H; H-3), 4,95 (sept;, IH, J = 6Hz; (CH3)2CH), 5,95 (s, IH, J = 4Hz; H-7), 6,68 (d, IH, J = 4Hz; H-6), 6,70-790 ppm. (m, 4H; phenylprotoner); M.S.: m/e 327 (M+), 3_o ’ isopropyl-5-niT'ethoxybenzoyl-l, 2-dihydro^3H-pyrrolo [1, 2-a] pyrrol--- 1-carboxylat smp. 50-51°C, isopropyl-5-p-ethoxybenzoyl-l,2-dihydro-3H-pyrrolo[1,2-a]pyrrol-l-carboxylat, smeltepunkt 94-95°C, 15 isopropyl-5-o-chlorbenzoyl-l,2-dihydro-3H-pyrrolo[1,2-a]pyrrol-l- ΜθΟΗ carboxylat, en olie med følgende fysiske konstanter: U.V.: \ma]£S 251, 306 nm (e 5750, 16600); I.R.: ^5^3 1735, 1625 cm"1; N.M.R. : 6TMs"L^ 1>22 (d» βΗ» (CH^)2ch), 2,55-3,05 (m, 2H; H-2), 3,97 (dd,.17 isopropyl-5-p-methoxybenzoyl-1,2-dihydro-3H-pyrrolo [1,2-a] pyrrole-1-carboxylate having the following physical constants: UV: 218, 270-284 (shoulder), 314 nm (e 9780, 9320, 22400); I.R. : 1717, 1605 cm -1; NMR: 1.24 (d, 6H, J = 6Hz; (CH3) 2CH-), δ 2.50-3.10 (m, 2H; H-2), 3.78 (s, 3H; CH 2 O), 3.93 (dd, 1H, = 6Hz, JBX = 7Hz; H1), 4.13-4.60 (Μ, 2H; H-3), 4, 95 (sept; 1H, J = 6Hz; (CH 3) 2CH), 5.95 (s, 1H, J = 4Hz; H-7), 6.68 (d, 1H, J = 4Hz; H-6) , 6.70-790 ppm (m, 4H; phenyl protons); MS: m / e 327 (M +), 3'-isopropyl-5-nitroethoxybenzoyl-1,2-dihydro-3H-pyrrolo [1,2 a] pyrrole --- 1-carboxylate mp 50-51 ° C, isopropyl-5-p-ethoxybenzoyl-1,2-dihydro-3H-pyrrolo [1,2-a] pyrrole-1-carboxylate, m.p. 95 ° C, isopropyl-5-o-chlorobenzoyl-1,2-dihydro-3H-pyrrolo [1,2-a] pyrrole-1-ΜθΜ carboxylate, an oil having the following physical constants: UV: 251, 306 nm (e 5750, 16600); IR: δ 5 1735, 1625 cm -1; N.M.R. : 6TMs < 1 > 22 (d < β > (CH2) 2ch), 2.55-3.05 (m, 2H; H-2), 3.97 (dd,.

IH, H-l), 4,17-4,70 (m, 2H, H-3), 4,97 (sept., IH, (CH3)2CH), 20 [5,93 (d, 2/3H), 6,00 (d, 1/3H) H-7], [6,42 (d, 2/3H), 6,67 (d, 1/3H), H-6], 7,07-7,80 ppm. (m, 4H; phenylprotoner), isopropyl-5-m-chlorbenzoyl-l,2-dihydro-3H-pyrrolo[1,2-a]pyrrol-l-carb= oxylat, en olie med følgende fysiske konstanter: U.V. : ^ 241, . CWH wd.ft.b_-.1H, H1), 4.17-4.70 (m, 2H, H-3), 4.97 (Sept., 1H, (CH3) 2CH), [5.93 (d, 2 / 3H), 6.00 (d, 1 / 3H) H-7], [6.42 (d, 2 / 3H), 6.67 (d, 1 / 3H), H-6], 7.07-7.80 ppm. (m, 4H; phenyl protons), isopropyl-5-m-chlorobenzoyl-1,2-dihydro-3H-pyrrolo [1,2-a] pyrrole-1-carb = oxylate, an oil having the following physical constants: U.V. : ^ 241 ,. CWH wd.ft.b_-.

313 nm (e 6600, 15100); I.R.: ^ks3 1735, l620’ 1570 cm ’ 25 N.M.R.: δ™13 1,27 (d, 6H, (CH3)2CH), 2,50-3,18 (m, 2H, H-2), 3,93 (dd, IH, H-l), 4,10-4,63 (m, 2H, H-3), 4,98 (sept., IH, (CH3)2CH), 5,98 (d, IH, H-7), 6,67 (d, IH, H-6), 7,07-7,78 ppm.313 nm (e 6600, 15100); IR: δ ks3 1735, 1620 '1570 cm-1 NMR: δ ™ 13 1.27 (d, 6H, (CH3) 2CH), 2.50-3.18 (m, 2H, H-2), 3, 93 (dd, 1H, H1), 4.10-4.63 (m, 2H, H-3), 4.98 (sept, 1H, (CH3) 2CH), 5.98 (d, 1H, H -7), 6.67 (d, 1H, H-6), 7.07-7.78 ppm.

(m, 4H, phenylprotoner); M.S.: m/e 331-333 (M+), isopropyl-5-p-chlorbenzoyl-l,2-dihydro-3H-pyrrolo[l,2-a]pyrrol-l-3q carboxylat, smeltepunkt 80,5-81°C, is opropyl-5-p-fluorbenzoyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrol-l-carboxylat, smeltepunkt 72-72,5°C.(m, 4H, phenyl protons); MS: m / e 331-333 (M +), isopropyl-5-p-chlorobenzoyl-1,2-dihydro-3H-pyrrolo [1,2-a] pyrrole-1-3q carboxylate, m.p. 80.5-81 ° C, is propyl 5-p-fluorobenzoyl-1,2-dihydro-3H-pyrrolo [1,2-a] pyrrole-1-carboxylate, m.p. 72-72.5 ° C.

1818

DK 151886BDK 151886B

Eksempel 3 I overensstemmelse med fremgangsmåden fra eksempel 1 kondenseres iso= propyl-1,2-dihydro-6-methyl-3H-pyrrolo[1,2-a]pyrrol-l-carboxylat med N,N-dimethyl-p-toluamid til fremstilling af isopropyl-5-p-toluoyl-l,2-dihydro-6-methyl-3H-pyrrolo[l,2-a]pyrrol-l-carboxylat (XI, R = CH^, R1 = p-CH3, R2 = iso-C^Hy), smp. 72°C~ På tilsvarende måde, men under anvendelse af de i eksempel .3 anførte Ν,Ν-dimethylarylamider i stedet for N,N-dimethyl-p-toluamid fås hen-1Q holdsvis: isopropyl-5-benzoyl-l,2-dihydro-6-methyl-3H-pyrrolo[l,2-a]pyrrol-l-carboxylat, smp. 75 C, isopropyl-5-p-methoxybenzoyl-l, 2-dlhydro-6-metHyl-3H-pyrrolo[ 1,2-a] 15 pyrrol-l-carboxylat, smp. 89°c, isopropyl-5-p-chlorbenzoyl-l,2-dihydro-6-methyl-3H-pyrrolo[1,2-a]pyr= rol-l-carboxylat, smp. 88QC, isopropyl-5-p-fluorbenzoyl-1,2-dihydro-6-me thyl-3H-pyrrolo[1,2-a]pyr= rol-l-carboxylat med følgende fysiske konstanter: 20 U.V. 250, 315 nm (e 6170, 14100); I.R. ^SSs3 1734» 16°5» 1593 cm”1; N.M.R. 1,25 (d, 6H, J = 6Hz; ester CH3), 1,83 (s, 3H; 25 ring CH3), 2,49-3,00 (m, 2H; CH2), 3,90 (t, IH, EJ = 7,4Hz; CHC0), 4,10-4,23 (m, 2H; N-CH2), 4,98 (sept., IH, J = 6Hz; ester CH), 5,84 (s, IH, H-3), 7,00 (t, 2H, Jortho = 8,4Hz, Jm = 8Hz; H-3',5'), 30 7,55 (q., 2H, 5Ϊ0Γ^0 = 8,4Hz, J·^, = 5»5Hz; H-2,6’)j M.S. m/e 1% 329 25 M+ 242 100 M+-C02CH(CH3)2 35 123 36 F-C6H4C0,Example 3 In accordance with the procedure of Example 1, iso = propyl-1,2-dihydro-6-methyl-3H-pyrrolo [1,2-a] pyrrole-1-carboxylate is condensed with N, N-dimethyl-p-toluamide to preparation of isopropyl 5-p-toluoyl-1,2-dihydro-6-methyl-3H-pyrrolo [1,2-a] pyrrole-1-carboxylate (XI, R = CH 2, R 1 = p-CH 3, R 2 = iso-C ^ Hy), m.p. 72 ° C ~ Similarly, but using the Ν, Ν-dimethylarylamides listed in Example 3. instead of N, N-dimethyl-p-toluamide, there is obtained -1Q respectively: isopropyl-5-benzoyl-1,2. -dihydro-6-methyl-3H-pyrrolo [1,2-a] pyrrole-1-carboxylate, m.p. 75 C, isopropyl 5-p-methoxybenzoyl-1,2-dihydro-6-methyl-3H-pyrrolo [1,2-a] pyrrole-1-carboxylate, m.p. 89 ° C, isopropyl 5-p-chlorobenzoyl-1,2-dihydro-6-methyl-3H-pyrrolo [1,2-a] pyrrole-1-carboxylate, m.p. 88 ° C, isopropyl 5-p-fluorobenzoyl-1,2-dihydro-6-methyl-3H-pyrrolo [1,2-a] pyrrole-1-carboxylate having the following physical constants: 20 U.V. 250, 315 nm (e 6170, 14100); I.R. ^ SSs3 1734 »16 ° 5» 1593 cm ”1; N.M.R. 1.25 (d, 6H, J = 6Hz; ester CH3), 1.83 (s, 3H; ring CH3), 2.49-3.00 (m, 2H; CH2), 3.90 (t, 1H, EJ = 7.4Hz; CHCO), 4.10-4.23 (m, 2H; N-CH2), 4.98 (sept., 1H, J = 6Hz; ester CH), 5.84 (s , 1H, H-3), 7.00 (t, 2H, Jortho = 8.4Hz, Jm = 8Hz; H-3 ', 5'), 7.55 (q., 2H, 5Ϊ0Γ , 4Hz, J · = = 5 »5Hz; H-2.6 ') MS m / e 1% 329 25 M + 242 100 M + -CO 2 CH (CH 3) 2 123 123 36 F-C 6 H 4 CO,

Claims (1)

25 R1_(fT'l) *"|j-Π ^ JL JL JL COOR2 (XI), a i_J 30 hvori R betegner hydrogen eller en alkylgruppe med 1-4 carbonatomer, R1 betegner hydrogen, en alkylgruppe med 1-4 carbonatomer, en alk= oxygruppe med 1-4 carbonatomer, chlor, fluor eller brom, og R2 er en alkylgruppe med 1-4 carbonatomer, ke'ndetegne't ved, at man 35 kondenserer en forbindelse af formlen DK 151886 B R\_ ! C00s2 2 hvor R og R har den ovenfor definerede betydning, med et qmid af formlen Έ>- CON (CH3).2 ' i i hvori R^ har den ovenfor definerede betydning. 1 i iWherein R represents hydrogen or an alkyl group having 1-4 carbon atoms, R1 represents hydrogen, an alkyl group having 1-4 carbon atoms, R1 represents (fT'l) * "| j-Π ^ JL JL JL COOR2 (XI) an alk = oxy group having 1-4 carbon atoms, chlorine, fluorine or bromine, and R2 is an alkyl group having 1-4 carbon atoms, characterized by condensing a compound of formula DK 151886 BR wherein R and R have the meaning defined above, with a qmid of the formula Έ> - CON (CH 3). 2 'ii wherein R 1 has the meaning defined above.
DK307577A 1976-07-14 1977-07-07 METHOD OF ANALOGUE FOR THE PREPARATION OF (DL) OR (1) 5-BENZOYL-1,2-DIHYDRO-3H-PYRROLOOE1,2-AAAPYRROL-1-CARBOXYL ACID ESTERS DK151886C (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
DK480080A DK151337C (en) 1976-07-14 1980-11-11 ANALOGY PROCEDURE FOR THE PREPARATION OF (DL) - OR (L) -5-BENZOYL-1,2-DIHYDRO-3H-PYRROLO (1,2-A) PYRROL-1-CARBOXYLIC ACID DERIVATIVES
DK479780A DK152733C (en) 1976-07-14 1980-11-11 (D) -5-BENZOYL-1,2-DIHYDRO-3H-PYRROLOOE1,2-AAA-PYRROL-1-CARBOXYLIC ACID OR ESTERS OR SALTS THEREOF USED AS INTERMEDIATES (PRODUCTS OF DELIVERED PRODUCTS)
DK479980A DK151336C (en) 1976-07-14 1980-11-11 ANALOGY PROCEDURE FOR PREPARING ONE (DL) - OR (L) -5-BENZOYL-1,2-DIHYDRO-3H-PYRROL (1,2-A) PYRROL-1-CARBOXYLIC ACID
DK479880A DK151335C (en) 1976-07-14 1980-11-11 METHOD OF ANALOGUE FOR THE PREPARATION OF (DL) - OR (L) -5-BENZOYL-1,2-DIHYDRO-3H-PYRROLO (1,2-A) PYRROL-1-CARBOXYLIC ACID ESTERS OR SALTS

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US70490976A 1976-07-14 1976-07-14
US70490976 1976-07-14
US05/771,286 US4089969A (en) 1976-07-14 1977-02-23 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof
US77128677 1977-02-23

Publications (3)

Publication Number Publication Date
DK307577A DK307577A (en) 1978-01-15
DK151886B true DK151886B (en) 1988-01-11
DK151886C DK151886C (en) 1988-06-06

Family

ID=27107410

Family Applications (1)

Application Number Title Priority Date Filing Date
DK307577A DK151886C (en) 1976-07-14 1977-07-07 METHOD OF ANALOGUE FOR THE PREPARATION OF (DL) OR (1) 5-BENZOYL-1,2-DIHYDRO-3H-PYRROLOOE1,2-AAAPYRROL-1-CARBOXYL ACID ESTERS

Country Status (27)

Country Link
JP (1) JPS539788A (en)
AR (1) AR224997A1 (en)
CA (1) CA1102809A (en)
CH (3) CH641458A5 (en)
CS (1) CS204954B2 (en)
DE (2) DE2731678A1 (en)
DK (1) DK151886C (en)
ES (2) ES460706A1 (en)
FI (1) FI63406C (en)
FR (2) FR2358406A1 (en)
GB (1) GB1554075A (en)
GR (1) GR61111B (en)
HK (1) HK15981A (en)
HU (1) HU174224B (en)
IE (1) IE45253B1 (en)
IL (2) IL52493A (en)
IT (1) IT1117313B (en)
MX (1) MX163202B (en)
MY (1) MY8100357A (en)
NL (2) NL186318C (en)
NO (1) NO147564C (en)
NZ (1) NZ184610A (en)
PL (4) PL124445B1 (en)
PT (1) PT66780B (en)
SE (1) SE434643B (en)
SU (1) SU695558A3 (en)
YU (1) YU40816B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4140698A (en) * 1977-07-25 1979-02-20 Syntex (Usa) Inc. 1,2-Dihydro-3H-pyrrolo[1,2-a]pyrrole-1-nitriles
JPS55124633A (en) * 1979-03-19 1980-09-25 Sohachi Takeuchi Manufacturing method of tubular vessel
US4344943A (en) * 1980-06-09 1982-08-17 Syntex (U.S.A.) Inc. 6-Chloro- or 6-bromo-1,2-dihydro-3H-pyrrolo[1,2-a]-pyrrole-1-carboxylic acids and derivatives thereof
US4353829A (en) * 1980-11-21 1982-10-12 Syntex (U.S.A.) Inc. Process for 5-aroylation of 1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic esters
US4511724A (en) * 1982-06-10 1985-04-16 Merck & Co., Inc. 5-(Pyrrol-2-oyl)-1,2-dihydro-3H-pyrrolo [1,2-a]pyrrole derivatives as anti-inflammatory and analgesic agents
JPS5910589A (en) * 1982-06-10 1984-01-20 メルク エンド カムパニー インコーポレーテツド Antiinflammatory and analgesic novel 5-(pyrrol-2-oyl)-1,2-dihydro-3h-pyrrolo(1,2-a) pyrrole derivative
US4874871A (en) * 1987-03-25 1989-10-17 Syntex (U.S.A.) Inc. Process for preparing (+)-2,3-Dihydro-1H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid and related compounds
JPH0739418B2 (en) * 1987-09-10 1995-05-01 久光製薬株式会社 Novel 3-aroyl-6,7-dihydro-5H-pyrrolo [1,2-c] imidazole-7-carboxylic acid derivative
JP2649168B2 (en) * 1988-02-25 1997-09-03 久光製薬株式会社 Novel 5,6-diphenyl-1,2-dihydro-3H-pyrrolo [1,2-a] pyrrole-1-carboxylic acid derivatives
IT1250691B (en) * 1991-07-22 1995-04-21 Giancarlo Santus THERAPEUTIC COMPOSITIONS FOR INTRANASAL ADMINISTRATION INCLUDING KETOROLAC.
CA2123109A1 (en) * 1991-11-11 1993-05-27 Kanji Noda Ketorolac-containing fomentation
DE4300697C1 (en) * 1993-01-13 1994-05-19 Roemmers Sa New 2-pyrrolidino-ethyl ester of ketorolac - useful as analgesic, antiinflammatory and antipyretic agent with low ulcerogenicity
US5622948A (en) * 1994-12-01 1997-04-22 Syntex (U.S.A.) Inc. Pyrrole pyridazine and pyridazinone anti-inflammatory agents
JP2008210666A (en) * 2007-02-27 2008-09-11 Okamura Corp Lighting system in merchandise display shelf
AU2021400215A1 (en) * 2020-12-16 2023-07-06 New Frontier Labs, Llc Dicarboxylic acid esters for inducing an analgesic effect

Also Published As

Publication number Publication date
IL52493A0 (en) 1977-10-31
DE2731678C2 (en) 1989-06-08
NO772494L (en) 1978-01-17
CS204954B2 (en) 1981-04-30
YU172177A (en) 1983-09-30
NL186318B (en) 1990-06-01
NL186318C (en) 1990-11-01
FI63406C (en) 1983-06-10
NL930021I1 (en) 1993-05-03
FR2375234B1 (en) 1980-11-07
GR61111B (en) 1978-09-12
IE45253B1 (en) 1982-07-14
PL124445B1 (en) 1983-01-31
SE434643B (en) 1984-08-06
NO147564B (en) 1983-01-24
HK15981A (en) 1981-05-01
PL124444B1 (en) 1983-01-31
IL58779A0 (en) 1980-02-29
SU695558A3 (en) 1979-10-30
SE7708141L (en) 1978-01-15
NZ184610A (en) 1979-03-28
FR2358406B1 (en) 1981-04-17
IE45253L (en) 1978-01-14
NL930021I2 (en) 1997-03-03
FI63406B (en) 1983-02-28
PL109390B1 (en) 1980-05-31
FI772153A7 (en) 1978-01-15
HU174224B (en) 1979-11-28
DK307577A (en) 1978-01-15
ES470214A1 (en) 1979-09-16
CH641458A5 (en) 1984-02-29
NO147564C (en) 1983-05-18
PT66780B (en) 1978-12-18
DE2731678A1 (en) 1978-03-16
PT66780A (en) 1977-08-01
ES460706A1 (en) 1978-12-01
YU40816B (en) 1986-06-30
AU2697577A (en) 1979-01-18
PL199603A1 (en) 1978-04-24
DK151886C (en) 1988-06-06
IL52493A (en) 1982-02-28
AU513384B2 (en) 1980-11-27
FR2375234A1 (en) 1978-07-21
MY8100357A (en) 1981-12-31
PL124711B1 (en) 1983-02-28
JPS539788A (en) 1978-01-28
CH646973A5 (en) 1984-12-28
FR2358406A1 (en) 1978-02-10
JPS6254109B2 (en) 1987-11-13
CH646972A5 (en) 1984-12-28
NL7707651A (en) 1978-01-17
GB1554075A (en) 1979-10-17
CA1102809A (en) 1981-06-09
DE2760330C2 (en) 1989-06-15
IT1117313B (en) 1986-02-17
AR224997A1 (en) 1982-02-15
MX163202B (en) 1992-02-20

Similar Documents

Publication Publication Date Title
DK151886B (en) METHOD OF ANALOGUE FOR THE PREPARATION OF (DL) OR (1) 5-BENZOYL-1,2-DIHYDRO-3H-PYRROLOOE1,2-AAAPYRROL-1-CARBOXYL ACID ESTERS
US4089969A (en) 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof
US4232038A (en) 5-Alkylsulfinylbenzoyl- and 5-alkylsulfonylbenzoyl-1,2-dihydro-3H-pyrrolo[1,]pyrrole-1-carboxylic acids
US4563525A (en) Process for preparing pyrazolopyridine compounds
US4097579A (en) 5-(2-Pyrroyl)-1,2-dihydro-3H-pyrrolo 1,2-a!pyrrole-1-carboxylic acid derivatives and process for the production thereof
IE912224A1 (en) "New 4-aminobutyric acid compounds, process for the preparation thereof and pharmaceutical preparations containing them"
DK152652B (en) ANALOGY PROCEDURE FOR PREPARING 5- (2-FUROYL) -, 5- (2-THENOYL) -, 5- (3-FUROYL) - AND 5- (3-THEONYL) -1,2-DIHYDRO-3H-PYRROLOOE1,2 -AAAPYRROL-1-carboxylic acid esters
NO161675B (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE BENZOYL-PYRROLO (1,2-A) PYRROL-CARBOXYLIC ACID DERIVATIVES.
NO742441L (en)
DK151336B (en) ANALOGY PROCEDURE FOR PREPARING ONE (DL) - OR (L) -5-BENZOYL-1,2-DIHYDRO-3H-PYRROL (1,2-A) PYRROL-1-CARBOXYLIC ACID
DK175516B1 (en) Process for the preparation of pyrrole derivatives
US4087433A (en) 1,5,10,11-Tetrahydrobenzo[4,5]-cyclohepta[1,2-b]pyrazolo[4,3-e]pyridines
US4508730A (en) 1,7-Dihydro-pyrrolo[3,4-e][1,4]diazepin-2(3H)-one derivatives a process for preparing them and their use as anticonvulsant and anti-anxiety agents
US4835288A (en) Process for preparing (+)-2,3-dihydro-1H-pyrrolo[1,2-a]pyrrole-1,7-dicarboxylates
Mamouni et al. Regioselective conversion of lactam to corresponding thiolactam in tetrahydropyrrolo [1, 2-a] thieno [3, 2-e][1, 3] diazepine
FI91148C (en) Alkyl 3-alkoxycarbonyl-2-pyrrolidinylidene carboxylates and process for their preparation
US5621115A (en) Methods for preparing 5-aroyl-1,2-dihydro-3H-pyrrolo-[1,2-A]pyrrole-1-carboxylic acids
US4127715A (en) Various 1,5,10,11-tetrahydrobenzo[4,5]cyclohepta[1,2-B]pyrazolo-[4,3-E]pyridine derivatives
US4849526A (en) Process for preparing (±)-2,3-dihydro-1H-pyrrolo[1,2-A]pyrrole-1,7-dicarboxylates
IT8247977A1 (en) PROCEDURE FOR THE PREPARATION OF ERGO ALKALOIDS
Anderson et al. Vinylogous carbinolamine tumor inhibitors. 11. Synthesis and antileukemic activity of fluorinated analogs of 2, 3-dihydro-5-phenyl-6, 7-bis (hydroxymethyl)-1H-pyrrolizine biscarbamate
DK152655B (en) METHOD OF ANALOGUE FOR THE PREPARATION OF (DL) - OR (L) -5- (2-FUROYL) -, 5- (2-THENOYL) -, 5- (3-FUROYL) - OR 5- (3-THENOYL) -1, 2-dihydro-3H-PYRROLOOE1,2-AAAPYRROL-1-carboxylic acid derivatives
Parlow An example of a novel formation of an oxepin
NZ235283A (en) Substituted pyrrole derivatives as synthesis intermediates
NO850400L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE TRICYCLIC NITROGEN CONTAINING DIONS